Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX

被引:29
|
作者
Hulikova, Alzbeta [1 ]
Zatovicova, Miriam [1 ]
Svastova, Eliska [1 ]
Ditte, Peter [1 ]
Brasseur, Robert [2 ]
Kettmann, Richard [3 ]
Supuran, Claudiu T. [4 ]
Kopacek, Juraj [1 ]
Pastorek, Jaromir [1 ]
Pastorekova, Silvia [1 ]
机构
[1] Slovak Acad Sci, Inst Virol, Bratislava 84505, Slovakia
[2] Fac Sci Agronom Gembloux, Ctr Biophys Mol Numer, B-5030 Gembloux, Belgium
[3] Fac Sci Agronom Gembloux, B-5030 Gembloux, Belgium
[4] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
来源
FEBS LETTERS | 2009年 / 583卷 / 22期
关键词
Carbonic anhydrase IX; pH regulation; Cell adhesion; Ectodomain shedding; Hypoxia; Acidosis; PROTEIN-PROTEIN INTERACTIONS; DOMAIN; PH; TRANSMEMBRANE; CANCER; INHIBITORS; RESIDUES; ADHESION; BINDING; GROWTHS;
D O I
10.1016/j.febslet.2009.10.060
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carbonic anhydrase IX (CA IX) is a tumor-associated, hypoxia-induced enzyme involved in pH regulation and cell adhesion. Its catalytically active ectodomain (ECD) is linked to a transmembrane region and a short intracellular (IC) tail. Removal of the IC tail causes intracellular localization of CA IX. Mutations of basic amino acids within IC do not perturb the membrane position, but reduce shedding of the CA IX ectodomain as well as CA IX-mediated cell dissociation. Moreover, they abolish the CA IX capacity to acidify extracellular pH (pHe) and bind CA IX-selective sulfonamide inhibitor in hypoxia. These findings provide the first evidence for the critical contribution of the IC tail to the proper functioning of CA IX. Structured summary: MINT-7293982: E-cadherin (uniprotkb:Q95LE0) and CA IX (genbank_protein_gi:223556027) colocalize (MI:0403) by fluorescence microscopy (MI:0416) (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:3563 / 3568
页数:6
相关论文
共 50 条
  • [31] Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides
    Pastorekova, S
    Vullo, D
    Casini, A
    Scozzafava, A
    Pastorek, J
    Nishimori, I
    Supuran, CT
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2005, 20 (03) : 211 - 217
  • [32] Carbonic anhydrase activators: Activation of the human tumor-associated isozymes IX and XII with amino acids and amines
    Pastorekova, Silvia
    Vullo, Daniela
    Nishimori, Isao
    Scozzafava, Andrea
    Pastorek, Jaromir
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (07) : 3530 - 3536
  • [33] A QSAR Study on Novel Series of Carbonic Anhydrase Inhibitors hCA IX-Tumor-Associated (Hypoxia)
    Singh, Shalini
    MEDICINAL CHEMISTRY, 2012, 8 (04) : 656 - 672
  • [34] Tumor-associated carbonic anhydrase IX maintains cellular proliferation by regulating tumor metabolism: a novel link revealed by proteomics
    Benej, Martin
    Svastova, Eliska
    Banova, Radivojka
    Kopacek, Juraj
    Gibadulinova, Adriana
    Kery, Martin
    Arena, Simona
    Scaloni, Andrea
    Vitale, Monica
    Zambrano, Nicola
    Papandreou, Ioanna
    Denko, Nicholas C.
    Pastorekova, Silvia
    CANCER RESEARCH, 2020, 80 (16)
  • [35] Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX
    Pastorekova, S
    Casini, A
    Scozzafava, A
    Vullo, D
    Pastorek, J
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (04) : 869 - 873
  • [36] Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII
    Rami, Marouan
    Maresca, Alfonso
    Smaine, Fatma-Zhora
    Montero, Jean-Louis
    Scozzafava, Andrea
    Winum, Jean-Yves
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (10) : 2975 - 2979
  • [37] Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides
    Jaiswal, M
    Khadikar, PV
    Scozzafava, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (12) : 3283 - 3290
  • [38] Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX
    Sharma, Aditi
    Tiwari, Meena
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2014, 29 (02) : 292 - 296
  • [39] Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds
    Puccetti, L
    Fasolis, G
    Cecchi, A
    Winum, JY
    Gamberi, A
    Montero, JL
    Scozzafava, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2359 - 2364
  • [40] Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII
    Ibrahim, Hany S.
    Abou-Seri, Sahar M.
    Tanc, Muhammet
    Elaasser, Mahmoud M.
    Abdel-Aziz, Hatem A.
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 103 : 583 - 593